Middlefield Expands Investment Platform With Experienced Fixed Income Team, Introducing Middlefield Short Duration Bond Plus Fund

SandRidge Energy (SD) reported Q2 2026 revenues of just over $51 million, up 48% year over year, and adjusted EBITDA of $34 million, up 49%. Net income was about $27 million, or $0.72 per share. The company said it has $115 million cash, no debt, and paid $10.6 million in dividends. It also discussed a Cherokee acquisition adding 7,000 net acres and 21 wells, 2026 capex guidance of $76 to $97 million, and hedges covering just under 30% of 2026 midpoint production.

SANDRIDGE ENERGY INC (SD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SandRidge Energy, Inc. Announces Financial and Operating Results for the Three and Six-Month Periods Ended June 30, 2026 and Declares Dividend of $0.13 per Share Oklahoma City, Oklahoma, August 5, 2026 / PRNewswire/ – SandRidge Energy, Inc. (the “Company” or “SandRid

SandRidge Energy (NYSE: SD) reported second-quarter 2026 net income of $26.7 million ($0.72 per basic share) and adjusted net income of $21.0 million ($0.57). Adjusted EBITDA was $34.0 million. The company declared a $0.13/share dividend payable Aug. 31, 2026. Cash was $114.7 million; it expects a Cherokee asset acquisition close in Q3 2026.

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.